These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31595639)

  • 41. Terbinafine gel.
    Scheinfeld NS
    Skinmed; 2008; 7(1):31-2. PubMed ID: 18174799
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe liver damage on terbinafine.
    Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985370
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and pharmacology of terbinafine and itraconazole.
    Leyden J
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S42-7. PubMed ID: 9594936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and safety of terbinafine in children.
    Gupta AK; Adamiak A; Cooper EA
    J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):627-40. PubMed ID: 14761128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute generalized exanthematous pustulosis induced by terbinafine in a child confirmed by patch testing.
    Zaouak A; Ben Salem F; Charfi O; Hammami H; Fenniche S
    Int J Dermatol; 2019 Feb; 58(2):e42-e43. PubMed ID: 30255495
    [No Abstract]   [Full Text] [Related]  

  • 46. [Terbinafine induced hepatitis with persistent cholestasis].
    Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
    Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
    [No Abstract]   [Full Text] [Related]  

  • 47. Terbinafine for dermatophytes in skin and nail.
    Drug Ther Bull; 1992 Jun; 30(12):47-8. PubMed ID: 1623815
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses.
    Villars V; Jones TC
    Clin Exp Dermatol; 1989 Mar; 14(2):124-7. PubMed ID: 2689015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute generalized exanthematous pustulosis due to terbinafine.
    Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
    Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of terbinafine in rare and refractory mycoses.
    Revankar SG; Nailor MD; Sobel JD
    Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Terbinafine and cholestatic hepatitis].
    Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
    Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute hepatitis related to the ingestion of terbinafine].
    Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
    Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
    [No Abstract]   [Full Text] [Related]  

  • 53. Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine.
    Olivier S; De Montjoye L; Tromme I; Baeck M
    Eur J Dermatol; 2018 Apr; 28(2):236-238. PubMed ID: 29336314
    [No Abstract]   [Full Text] [Related]  

  • 54. Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine.
    Bhari N; Sahni K; Dev T; Sharma VK
    Int J Dermatol; 2017 Aug; 56(8):e168-e170. PubMed ID: 28244137
    [No Abstract]   [Full Text] [Related]  

  • 55. Dermatomycoses in the Israeli defense forces-Epidemiological and clinical aspects.
    Ravid A; Michael F; Daniel C; Esther S
    Mycoses; 2020 Jan; 63(1):65-70. PubMed ID: 31599024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Itraconazole, terbinafine possibly linked to liver failure.
    Am J Health Syst Pharm; 2001 Jun; 58(12):1076. PubMed ID: 11449844
    [No Abstract]   [Full Text] [Related]  

  • 57. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature.
    Gupta AK; Lynde CW; Lauzon GJ; Mehlmauer MA; Braddock SW; Miller CA; Del Rosso JQ; Shear NH
    Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of cutaneous sporotrichosis with terbinafine.
    Hull PR; Vismer HF
    Br J Dermatol; 1992 Feb; 126 Suppl 39():51-5. PubMed ID: 1543674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case of generalized pustular psoriasis that might have progressed from terbinafine-induced acute generalized exanthematous pustulosis.
    Yasuno S; Yamaguchi M; Tanaka A; Umehara K; Okita T; Asano N; Kashiwagi K; Shimomura Y
    J Dermatol; 2018 Dec; 45(12):e328-e329. PubMed ID: 29766566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.